Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2014 · limited liability company

Assets managed$4.5bn
Staff11 · 11 in investment roles
Main clients (by assets)Private funds 100%
Private funds7 (1 hedge) · $4.5bn gross assets
Form ADV · 2026-04-28SEC adviser record

Legal entityVENROCK ADVISER, LLC (US)

$3.3bn reported value +23.1% vs Q1 2026

33positions

80.4%in top 10

4 new 5 added 5 reduced 4 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	APOGEE THERAPEUTICS INC COM COM		8,493,321	$1.1bn34.18%	34.18%	Unchanged
2	ORUKA THERAPEUTICS INC COM ORKA	ORKA	4,148,428	$394.8m11.97%	11.97%	Unchanged
3	ERASCA INC COM ERAS	ERAS	17,891,812	$327.8m9.94%	9.94%	Added +1.5m	+1,509,000 9.2%
4	SPYRE THERAPEUTICS INC COM NEW SYRE	SYRE	2,985,448	$265.0m8.04%	8.04%	Reduced -700.0k	-700,000 -19.0%
5	DIANTHUS THERAPEUTICS INC COM DNTH	DNTH	1,180,000	$115.0m3.49%	3.49%	Unchanged
6	OCULAR THERAPEUTIX INC COM OCUL	OCUL	10,346,926	$101.6m3.08%	3.08%	Unchanged
7	DAMORA THERAPEUTICS INC COM NEW COM NEW		3,603,595	$93.7m2.84%	2.84%	Unchanged
8	SAVARA INC COM SVRA	SVRA	14,745,943	$90.8m2.75%	2.75%	Added +1.0m	+1,005,568 7.3%
9	JADE BIOSCIENCES INC COM NEW JBIO	JBIO	3,220,364	$71.6m2.17%	2.17%	Unchanged
10	COGENT BIOSCIENCES INC COM COGT	COGT	1,642,166	$63.6m1.93%	1.93%	Reduced -357.8k	-357,834 -17.9%
11	VIRIDIAN THERAPEUTICS INC COM VRDN	VRDN	3,257,917	$59.8m1.81%	1.81%	Reduced -624.8k	-624,792 -16.1%
12	VOR BIOPHARMA INC COM NEW VOR	VOR	3,041,719	$56.0m1.70%	1.70%	Unchanged
13	DYNE THERAPEUTICS INC COM DYN	DYN	2,173,913	$48.3m1.46%	1.46%	Unchanged
14	MAZE THERAPEUTICS INC COM MAZE	MAZE	1,602,034	$47.8m1.45%	1.45%	Unchanged
15	RELMADA THERAPEUTICS INC COM RLMD	RLMD	6,844,305	$47.4m1.44%	1.44%	Added +2.0m	+2,000,925 41.3%
16	ORIC PHARMACEUTICALS INC COM ORIC	ORIC	4,319,765	$46.8m1.42%	1.42%	Unchanged
17	CRESCENT BIOPHARMA INC. COM CBIO	CBIO	2,133,576	$38.4m1.16%	1.16%	Unchanged
18	ZURA BIO LTD CLASS A ORD SHS ZURA	ZURA	6,434,990	$38.0m1.15%	1.15%	Unchanged
19	ADLAI NORTYE LTD SPONSORED ADS ANL	ANL	3,212,731	$36.9m1.12%	1.12%	Unchanged
20	ENLIVEN THERAPEUTICS INC COM ELVN	ELVN	526,331	$26.7m0.81%	0.81%	Reduced -1.2m	-1,200,000 -69.5%
21	CYBIN INC COM NEW COM NEW		3,851,654	$25.5m0.77%	0.77%	Unchanged
22	CULLINAN THERAPEUTICS INC COM CGEM	CGEM	1,379,965	$25.1m0.76%	0.76%	Unchanged
23	CENTURY THERAPEUTICS INC COM IPSC	IPSC	8,695,652	$21.3m0.65%	0.65%	Unchanged
24	ARTIVA BIOTHERAPEUTICS INC COM ARTV	ARTV	2,043,596	$19.8m0.60%	0.60%	Added +434.0k	+434,027 27.0%
25	CYTOMX THERAPEUTICS INC COM CTMX	CTMX	4,982,124	$18.7m0.57%	0.57%	Reduced -5.0m	-5,000,000 -50.1%
26	ACHIEVE LIFE SCIENCES INC COM ACHV	ACHV	2,751,032	$18.0m0.54%	0.54%	New
27	PARABILIS MEDICINES INC COM PBLS	PBLS	625,000	$17.1m0.52%	0.52%	New
28	SURROZEN INC COM NEW SRZN	SRZN	632,931	$16.4m0.50%	0.50%	Unchanged
29	KORRO BIO INC COM KRRO	KRRO	1,009,500	$13.3m0.40%	0.40%	Unchanged
30	ALTO NEUROSCIENCE INC COM SHS ANRO	ANRO	500,000	$13.2m0.40%	0.40%	Unchanged
31	X4 PHARMACEUTICALS INC COM NEW XFOR	XFOR	1,934,253	$9.0m0.27%	0.27%	Added +1.6m	+1,603,728 485.2%
32	RESEARCH ALLIANCE CORP III ORD SHS CL A RACC	RACC	300,000	$3.2m0.10%	0.10%	New
33	INMED PHARMACEUTICALS INC COM NEW INM	INM	32,685	$50.7k0.00%	0.00%	New

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
KALVISTA PHARMACEUTICALS INC KALV	KALV	6,474,485	$130.3m6.5m shares
ENGENE HOLDINGS INC		4,771,414	$32.5m4.8m shares
TENAX THERAPEUTICS INC TENX	TENX	1,675,262	$26.8m1.7m shares
SEPTERNA INC SEPN	SEPN	506,056	$12.2m506.1k shares